Calando Pharmaceuticals, Inc. is majority-owned and operated by Arrowhead Research Corporation. For more information about Calando's RONDEL small RNA delivery technology and CALAA-01, Calando's first therapeutic to undergo clinical testing, please visit Arrowhead's website at www.arrowheadresearch.c...